Physician profile
Ramon Castello
NPI 1811984073
$20,621.19
in general payments reported to CMS, 2019-2025
41 companies · $1,582 in 2025
The $1,582 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $890 · 2021: $2,291 · 2022: $1,841 · 2023: $1,801 · 2024: $1,559 · 2025: $1,582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,937 · Education: $6.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,936.73 |
| Education | $6.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $9,966.55 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $1,349.22 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,042.18 | 2019-2025 | Farxiga, Lokelma, Wainua |
| Janssen Pharmaceuticals, INC | $876.56 | 2019-2024 | Xarelto |
| Pfizer INC. | $780.15 | 2019-2025 | |
| Abbott Laboratories | $754.02 | 2020-2025 | Mitraclip, Xact, Cardiomems |
| Edwards Lifesciences Corporation | $689.36 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $642.14 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $590.03 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $584.04 | 2021-2025 | Verquvo, Capvaxive |
| Amgen INC. | $467.24 | 2019-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $374.53 | 2019-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $358.03 | 2021-2025 | Opsumit, Uptravi |
| Medtronic, INC. | $277.66 | 2021-2023 | Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $229.36 | 2019-2025 | Lifevest |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $210.26 | 2022-2023 | Optimizer |
| Philips North America LLC | $150.55 | 2022-2023 | |
| Esperion Therapeutics, INC. | $145.73 | 2020-2024 | Nexletol |
| Lundbeck LLC | $132.94 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $124.93 | 2023-2024 | Inpefa |
| Cvrx, INC. | $119.42 | 2022-2025 | Barostim Neo System |
| Novo Nordisk INC | $100.81 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $96.23 | 2025 | Amvuttra |
| Amarin Pharma, INC. | $86.09 | 2019-2021 | |
| Gilead Sciences, INC. | $59.51 | 2019 | |
| Medicomp INC | $54.62 | 2022 | |
| Irhythm Technologies, INC. | $41.76 | 2023 | Zio Xt Patch |
| Vifor Pharma, INC. | $34.36 | 2024 | Veltassa |
| Baxter Healthcare | $31.87 | 2023 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Lantheus Medical Imaging, INC. | $31.62 | 2019-2020 | |
| Bardy Diagnostics, INC. | $27.50 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $26.77 | 2022 | |
| Inspire Medical Systems, INC. | $25.64 | 2024 | Inspire |
| Genzyme Corporation | $23.51 | 2022 | |
| Scpharmaceuticals INC. | $22.25 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $20.50 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.04 | 2019 | |
| Ge Healthcare | $15.11 | 2021 | |
| G Medical Diagnostic Services, INC. | $14.60 | 2021 | |
| Medtronic Vascular, INC. | $14.29 | 2020 | |
| Shockwave Medical, INC | $11.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Castello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.